3B Blackbio Dx Key Ratios
BSE: 532067
₹1,334.40
₹-14.90
(-1.10%)
As on 23-Oct-2026IST
Market cap
₹1,144 Cr
Revenue (TTM)
₹153 Cr
P/E Ratio
20.6
P/B Ratio
3.4
Div. Yield
0.4 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -5.48 | 50.62 | 54.30 | 33.46 | -5.80 |
| EBIT | 56.00 | -37.88 | -5.29 | 16.99 | -18.44 |
| Net Profit | -0.25 | -24.28 | 13.24 | 25.29 | -9.00 |
| EPS | -0.24 | -24.28 | 13.23 | 24.08 | -11.37 |
| Book Value | -- | -- | 20.85 | 18.83 | 16.52 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 52.08 | 44.23 | 30.86 | 36.39 | 50.82 |
| Net Margin
| 43.50 | 37.98 | 31.16 | 35.78 | 42.75 |
| Return on equity
| 20.94 | 18.52 | 17.84 | 20.22 | 19.41 |
| Return on Capital
| 28.17 | 24.66 | -- | 25.90 | 26.03 |
| Return on Assets
| 19.03 | 15.74 | 16.70 | 17.79 | 17.54 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.01 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
25.90
|
26.03
|
21.21
|
20.24
|
29.92
|
|
|
|
|
|
|
Peer Median
|
--
|
16.22
|
12.22
|
21.63
|
27.13
|
26.41
|
|
|
|
|
|
ROE
17.84
Higher than Peers by 6.29
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
17.84
|
20.22
|
19.41
|
15.42
|
14.98
|
22.59
|
|
|
|
|
|
|
Peer Median
|
11.55
|
12.46
|
9.23
|
18.08
|
23.65
|
21.83
|
|
|
|
|
|
ROA
16.70
Higher than Peers by 9.43
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
16.70
|
17.79
|
17.54
|
13.89
|
12.77
|
16.70
|
|
|
|
|
|
|
Peer Median
|
7.27
|
7.01
|
5.98
|
9.92
|
11.99
|
10.73
|
|
|
|
|
|
EBIT Margin
30.86
Higher than Peers by 22.13
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
30.86
|
36.39
|
50.82
|
43.07
|
45.68
|
45.17
|
|
|
|
|
|
|
Peer Median
|
8.73
|
10.14
|
9.68
|
7.64
|
15.61
|
14.45
|
|
|
|
|
|
Net Margin
31.16
Higher than Peers by 24.26
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
31.16
|
35.78
|
42.75
|
37.04
|
37.54
|
36.78
|
|
|
|
|
|
|
Peer Median
|
6.90
|
6.37
|
5.63
|
8.97
|
12.29
|
11.31
|
|
|
|
|
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.00
|
45.84
|
50.56
|
44.73
|
43.34
|
40.76
|
|
|
|
|
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Revenue Growth
54.30
Higher than Peers by 47.45
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
54.30
|
47.11
|
30.14
|
19.87
|
-23.32
|
-64.43
|
|
|
|
|
|
|
Peer Median
|
6.85
|
8.30
|
7.71
|
-11.85
|
28.76
|
12.22
|
|
|
|
|
|
EBIT Growth
-5.29
Lower than Peers by 19.27
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
-5.29
|
5.36
|
53.56
|
13.02
|
-22.45
|
-75.61
|
|
|
|
|
|
|
Peer Median
|
13.99
|
17.99
|
31.57
|
-36.92
|
24.92
|
27.46
|
|
|
|
|
|
Net Profit Growth
13.24
Lower than Peers by 1.04
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
13.24
|
25.66
|
48.56
|
23.77
|
-19.45
|
-71.72
|
|
|
|
|
|
|
Peer Median
|
14.28
|
19.26
|
30.59
|
-41.41
|
25.31
|
37.91
|
|
|
|
|
|
EPS Growth
13.23
Higher than Peers by 1.76
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
13.23
|
25.66
|
48.56
|
23.74
|
-29.55
|
-71.72
|
|
|
|
|
|
|
Peer Median
|
11.47
|
30.16
|
31.07
|
-42.07
|
26.92
|
38.53
|
|
|
|
|
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
20.85
|
20.34
|
15.42
|
26.29
|
15.88
|
|
|
|
|
|
|
Peer Median
|
Solvency
Debt to Equity
0.01
Higher than Peers by 0.00
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.01
|
0.01
|
0.00
|
0.00
|
0.01
|
0.02
|
|
|
|
|
|
|
Peer Median
|
0.00
|
0.11
|
0.05
|
0.11
|
0.09
|
0.09
|
|
|
|
|
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
--
|
--
|
0.00
|
0.01
|
0.01
|
|
|
|
|
|
|
Peer Median
|
Current Ratio
5.27
Higher than Peers by 3.32
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
5.27
|
5.27
|
7.11
|
7.04
|
8.05
|
4.82
|
|
|
|
|
|
|
Peer Median
|
1.95
|
1.79
|
2.07
|
1.63
|
1.80
|
1.85
|
|
|
|
|
|
Quick Ratio
4.77
Higher than Peers by 3.49
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
4.77
|
4.77
|
6.64
|
6.56
|
7.49
|
4.38
|
|
|
|
|
|
|
Peer Median
|
1.28
|
1.13
|
1.23
|
1.13
|
0.96
|
1.23
|
|
|
|
|
|
Interest Coverage
226.91
Higher than Peers by 207.42
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
226.91
|
325.63
|
590.84
|
357.08
|
178.97
|
407.23
|
|
|
|
|
|
|
Peer Median
|
19.49
|
17.49
|
12.22
|
12.03
|
32.38
|
25.98
|
|
|
|
|
|
Operating Efficiency
Debtors to sales
32.70
Higher than Peers by 1.16
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
32.70
|
35.29
|
37.86
|
48.90
|
54.89
|
37.17
|
|
|
|
|
|
|
Peer Median
|
31.54
|
31.06
|
30.54
|
25.72
|
30.34
|
28.66
|
|
|
|
|
|
Asset Turnover
0.45
Lower than Peers by 0.40
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.45
|
0.42
|
0.35
|
0.32
|
0.30
|
0.42
|
|
|
|
|
|
|
Peer Median
|
0.85
|
0.86
|
0.85
|
0.88
|
1.09
|
1.14
|
|
|
|
|
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
111.38
|
137.66
|
172.80
|
188.65
|
146.56
|
|
|
|
|
|
|
Peer Median
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
34.87
|
32.48
|
40.55
|
45.68
|
27.85
|
|
|
|
|
|
|
Peer Median
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
45.25
|
42.09
|
61.16
|
70.42
|
37.45
|
|
|
|
|
|
|
Peer Median
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
101.00
|
128.05
|
152.20
|
163.91
|
136.97
|
|
|
|
|
|
|
Peer Median
|
Valuation
Price / Earnings
20.60
Higher than Peers by 0.08
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
20.60
|
16.10
|
29.05
|
20.54
|
13.73
|
7.94
|
|
|
|
|
|
|
Peer Median
|
20.52
|
19.87
|
39.81
|
50.05
|
19.11
|
27.36
|
|
|
|
|
|
Price / Book Value
3.43
Higher than Peers by 1.17
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
3.43
|
2.97
|
5.16
|
2.96
|
1.84
|
1.67
|
|
|
|
|
|
|
Peer Median
|
2.26
|
2.44
|
4.60
|
3.48
|
3.99
|
5.38
|
|
|
|
|
|
Dividend Yield
0.38
Higher than Peers by 0.01
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.38
|
0.44
|
0.25
|
0.39
|
0.60
|
3.08
|
|
|
|
|
|
|
Peer Median
|
0.36
|
0.34
|
0.20
|
0.55
|
0.35
|
0.25
|
|
|
|
|
|
EV/EBITDA
12.94
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
12.94
|
10.53
|
20.20
|
13.14
|
8.22
|
5.21
|
|
|
|
|
|
|
Peer Median
|
--
|
14.03
|
29.16
|
19.72
|
17.29
|
22.13
|
|
|
|
|
|
Market Cap
1,144
Lower than Peers by 1,394
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
1,144
|
965
|
1,385
|
659
|
356
|
256
|
|
|
|
|
|
|
Peer Median
|
2,538
|
2,053
|
4,155
|
3,052
|
3,521
|
3,428
|
|
|
|
|
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
